SCHEMBL27259282

SCHEMBL27259282

C[C@@H](Oc1ccc(Oc2ccc3cc(Cl)ccc3n2)cc1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.56
MAPT P10636 2/20 0.56
ALDH1A1 P00352 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
TP53 P04637 1/20 0.56
CYP3A4 P08684 1/20 0.56
ALOX15 P16050 1/20 0.56
NFKB1 P19838 1/20 0.56
HIF1A Q16665 1/20 0.56
GMNN O75496 1/20 0.56
LMNA P02545 1/20 0.56
HPGD P15428 1/20 0.56
APEX1 P27695 1/20 0.56
PMP22 Q01453 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
TSHR P16473 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
HTR2B P41595 1/20 0.45
MAP4K4 O95819 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9587966 1.00 CYP1A2 (0.56) CYP1A2MAPTALDH1A1SMN1; SMN2TP53
SCHEMBL3887207 0.91 CYP1A2 (0.57) CYP1A2MAPTALDH1A1SMN1; SMN2TP53
SCHEMBL3885170 0.91 CYP1A2 (0.57) CYP1A2MAPTALDH1A1SMN1; SMN2TP53
SCHEMBL3573474 0.91 CYP1A2 (0.57) CYP1A2MAPTALDH1A1SMN1; SMN2TP53
SCHEMBL11114198 0.90 MAPT (0.56) CYP1A2MAPTALDH1A1SMN1; SMN2TP53
SCHEMBL10414560 0.90 MAPT (0.56) CYP1A2MAPTALDH1A1SMN1; SMN2TP53
SCHEMBL30469352 0.90 MAPT (0.56) CYP1A2MAPTALDH1A1SMN1; SMN2TP53
SCHEMBL3893051 0.90 CYP1A2 (0.56) CYP1A2MAPTALDH1A1SMN1; SMN2TP53
SCHEMBL7610992 0.88 MAPT (0.56) CYP1A2MAPTALDH1A1SMN1; SMN2TP53
Potassium Ion SCHEMBL10913562 0.88 MAPT (0.69) CYP1A2MAPTALDH1A1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024132001-A1 MULTITARGET NUCLEAR RECEPTOR LIGANDS BASED ON 2-(4-(QUINOLIN-2-YLOXY)PHENOXY)PROPANOIC ACID AND 2-(4-(QUINOXALIN-2-YLOXY)PHENOXY)PROPANOIC ACID FOR THE TREATMENT OF METABOLIC AND LIVER DISEASES CHARLES UNIVERSITY, FACULTY OF PHARMACY IN HRADEC KRALOVE (CZ) 2024-06-27 WO disclosed